Searched for
BIOLOGICAL E INVESTMENT
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- ‘It's a big price tag’: Bryan Johnson explains why international travel affects sleep, cortisol and overall health, tech millionaire says it takes "two weeks to recover"Tech millionaire Bryan Johnson advocates for limiting international travel to once every three months, citing a significant biological cost...
- No slowdown yet, but inflation and El Niño are risks: ITC's Sanjiv PuriITC Chairman Sanjiv Puri revealed plans for a Rs 20,000 crore investment over the medium term, including hotel expansion. He highlighted st...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- South Korean shares hit record high on export surge, Nvidia optimismSouth Korean stocks surged to record highs on Monday. Strong chip exports fueled the rally, boosted by hopes of AI collaborations with Nvid...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Tom Kane cause of death: Beloved voice actor behind Yoda and Powerpuff Girls’ Professor dies at 64- here's what happened to himLegendary voice actor Tom Kane, known for his iconic roles as Yoda in Star Wars: The Clone Wars and Professor Utonium in The Powerpuff Girl...
- Curb your overenthusiasm: Why India must avoid early overregulation while drafting rules for new techIndia faces a critical choice in regulating new industries like AI and genomics. Overly cautious, ex-ante regulations, similar to the histo...
- Why do tigers rest for 16–20 hours a day? IITian-IFS officer shares fascinating explanation.Tigers need long rest periods for survival. IFS officer Himanshu Tyagi explains this is due to energy conservation. Tigers understand calor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- These 5 books helped Ankur Warikoo master his habits, mindset, and careerEntrepreneur Ankur Warikoo revealed five books that profoundly shaped his thinking and approach to work. These influential titles, includin...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Biological E to invest Rs 1800 crore to augment vaccine capacity, injectables, R&DAccording to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines a...
- Vaccine-making in India for Indo-Pacific region to exceed $1 billion by 2022The US had said it would work via its DFC to finance Biological E's efforts to produce at least 1 billion Covid-19 vaccine doses for India ...
- CEPI to invest $5m in Biological E’s projectCEPI has also agreed to an initial contribution of up to $5 million to Hyderabad-based Biological E towards the cost of scaling up the proc...
Load More
